GLYXAMBI 25/5MG TABLET

Ingredent : Empagliflozin (25 mg) + Linagliptin (5 mg)

Use for : GLYXAMBI 25/5MG TABLET – Used for managing type 2 diabetes.

Units : Packing of 10 Tablets Strip

1. Indications
    – Type 2 Diabetes Management: GLYXAMBI 25/5MG TABLET is indicated for the treatment of adults with type 2 diabetes, helping to improve glycemic control when used in conjunction with diet and exercise.

    – Cardiovascular Risk Reduction: Empagliflozin in the formulation has also shown cardiovascular benefits, reducing the risk of heart disease in patients with type 2 diabetes.

 
2. Benefits
The use of GLYXAMBI 25/5MG TABLET provides several important benefits:

    – Dual Action: The combination of Empagliflozin and Linagliptin allows for a comprehensive approach to blood sugar control, targeting multiple pathways involved in glucose regulation.

    – Weight Management: Patients may experience weight loss or maintenance as a result of the SGLT2 inhibition from Empagliflozin, which encourages the excretion of glucose through urine.

    – Improved Cardiovascular Health: Empagliflozin has been associated with improved heart health and reduced cardiovascular risks for individuals with diabetes.

 
3. Dosage and Administration
It is essential to follow the recommended dosage and administration instructions for GLYXAMBI 25/5MG TABLET to ensure optimal results:

    – Recommended Dosage: The typical adult dosage is one tablet taken orally once daily, with or without food.

    – Administration: It is recommended to take the medication at the same time each day to help maintain consistent blood sugar levels.

    – Missed Dose: If a dose is missed, take it as soon as remembered. If its close to the time for the next dose, skip the missed dose and resume the regular schedule.

 
4. Mechanism of Action
GLYXAMBI 25/5MG TABLET works through two main mechanisms:

    – Empagliflozin: As an SGLT2 inhibitor, it prevents the reabsorption of glucose in the kidneys, leading to increased glucose excretion in urine and lowering blood sugar levels.

    – Linagliptin: This DPP-4 inhibitor increases incretin levels, which helps regulate insulin secretion in response to meals and decreases glucagon production, further aiding in blood sugar control.

 
5. Side Effects
While GLYXAMBI 25/5MG TABLET is generally safe and effective, some individuals may experience side effects. Common side effects include:

    – Genital Infections: Increased risk of urinary tract infections and genital mycotic infections due to increased glucose in the urine.

    – Gastrointestinal Symptoms: Some patients may experience nausea, diarrhea, or abdominal discomfort.

    – Dehydration: Potential for dehydration due to osmotic diuresis, leading to symptoms such as dizziness or hypotension.

 
6. Precautions
Before taking GLYXAMBI 25/5MG TAB, consider the following precautions:

    – Kidney Function: Monitor kidney function regularly, as Empagliflozin should be used cautiously in patients with impaired renal function.

    – Hypoglycemia Risk: While the risk of hypoglycemia is lower with this medication, it is important to be aware of symptoms and manage them accordingly.

    – Pregnancy and Breastfeeding: Consult a healthcare provider if pregnant, planning to become pregnant, or breastfeeding, as the effects on the fetus or infant are not fully established.

 
7. Conclusion
In conclusion, GLYXAMBI 25/5MG TABLET is an effective medication for managing type 2 diabetes in adults. Its dual-action formulation helps lower blood sugar levels, aids in weight management, and offers cardiovascular protection. Patients should adhere to the prescribed dosage and work closely with their healthcare provider to monitor their condition and manage any potential side effects.